{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T20:55:10Z","timestamp":1793912110283,"version":"4.8.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"7-8","license":[{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1016\/j.cca.2009.12.026","type":"journal-article","created":{"date-parts":[[2010,1,15]],"date-time":"2010-01-15T00:54:54Z","timestamp":1263516894000},"page":"459-466","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":75,"title":["Roles of COX inhibition in pathogenesis of NSAID-induced small intestinal damage"],"prefix":"10.1016","volume":"411","author":[{"given":"Koji","family":"Takeuchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kikuko","family":"Amagase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Satoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2009.12.026_bib1","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0090-6980(77)90178-2","article-title":"Resistance of germ-free rats to indomethacin-induced intestinal inflammation","volume":"14","author":"Robert","year":"1977","journal-title":"Prostaglandins"},{"key":"10.1016\/j.cca.2009.12.026_bib2","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/BF01694504","article-title":"Indomethacin induced intestinal inflammation","volume":"22","author":"Fang","year":"1977","journal-title":"Am J Dig Dis"},{"key":"10.1016\/j.cca.2009.12.026_bib3","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/0016-5085(87)90909-7","article-title":"Nonsteroidal anti-inflammatory drug-induced intestinal inflammation in humans","volume":"93","author":"Bjarnason","year":"1987","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cca.2009.12.026_bib4","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/0016-5085(81)90196-7","article-title":"Temporal relationship between cyclooxygenase inhibition, as measured by prostacyclin biosynthesis, and the gastrointestinal damage induced by indomethacin in the rat","volume":"80","author":"Whittle","year":"1981","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cca.2009.12.026_bib5","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1159\/000138047","article-title":"Indomethacin-increased gastrointestinal lesions in relation to tissue concentration, food intake and bacterial invasion in the rat","volume":"30","author":"Weissenborn","year":"1985","journal-title":"Pharmacology"},{"key":"10.1016\/j.cca.2009.12.026_bib6","first-page":"G903","article-title":"Indomethacin-induced leukocyte adhesion in mesenteric venules: role of lipoxygenase products","volume":"262","author":"Asako","year":"1992","journal-title":"Am J Physiol"},{"key":"10.1016\/j.cca.2009.12.026_bib7","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/BF00920471","article-title":"Mechanisms of acute and chronic intestinal inflammation induced by indomethacin","volume":"17","author":"Yamada","year":"1993","journal-title":"Inflammation"},{"key":"10.1016\/j.cca.2009.12.026_bib8","first-page":"405","article-title":"Dual action of nitric oxide in pathogenesis of indomethacin-induced small intestinal ulceration in rats","volume":"50","author":"Tanaka","year":"1999","journal-title":"J Physiol Pharmacol"},{"key":"10.1016\/j.cca.2009.12.026_bib9","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1006\/phrs.1999.0550","article-title":"Roles of enterobacteria, nitric oxide and neutrophil in pathogenesis of indomethacin-induced small intestinal lesions in rats","volume":"40","author":"Konaka","year":"1999","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.cca.2009.12.026_bib10","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1023\/A:1014725024519","article-title":"16,16-dimethyl prostaglandin E2 inhibits indomethacin-induced small intestinal lesions through EP3 and EP4 receptors","volume":"47","author":"Kunikata","year":"2002","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cca.2009.12.026_bib11","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1053\/gast.1996.v111.pm8690211","article-title":"Characterization of prostaglandin G\/H synthase 1 and 2 in rat, dog, monkey, and human gastrointestinal tracts","volume":"111","author":"Kargman","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cca.2009.12.026_bib12","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/ddr.430250402","article-title":"Mitogen-inducible prostaglandin G\/H synthase: a new target for nonsteroidal antiinflammatory drugs","volume":"25","author":"Xie","year":"1992","journal-title":"Drug Dev Res"},{"key":"10.1016\/j.cca.2009.12.026_bib13","doi-asserted-by":"crossref","first-page":"12013","DOI":"10.1073\/pnas.91.25.12013","article-title":"Pharmacological and biochemical demonstration of the role of cyclo-oxygenase 2 in inflammation and pain","volume":"91","author":"Seibert","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cca.2009.12.026_bib14","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/0092-8674(95)90126-4","article-title":"Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration","volume":"83","author":"Langenbach","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.cca.2009.12.026_bib15","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/S0022-3565(25)10713-1","article-title":"Pharmacology of a selective cyclooxygenase-2 inhibitor L-745337: a novel non-steroidal anti-inflammatory agent with an ulcerogenic sparing effect in rat and non-human primate stomach","volume":"274","author":"Chan","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.cca.2009.12.026_bib16","doi-asserted-by":"crossref","first-page":"365","DOI":"10.2170\/jjphysiol.49.365","article-title":"Prostaglandin E2-activated housekeeping Cl\u2212 channels in the basolateral membrane of rat gastric parietal cells","volume":"49","author":"Ikari","year":"1999","journal-title":"Jpn J Physiol"},{"key":"10.1016\/j.cca.2009.12.026_bib17","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1006\/abbi.1993.1601","article-title":"Cloning two isoforms of rat cyclooxygenase: differential regulation of their expression","volume":"307","author":"Feng","year":"1993","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.cca.2009.12.026_bib18","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/0014-5793(93)80263-T","article-title":"Expression of mRNA for cyclooxygenase-1 and cyclooxygenase-2 in human tissues","volume":"330","author":"O'Neill","year":"1993","journal-title":"FEBS"},{"key":"10.1016\/j.cca.2009.12.026_bib19","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0090-6980(94)90074-4","article-title":"NS-398, a new antiinflammatory agent, selectively inhibits prostaglandin G\/H synthase\/cyclo-oxygenase (COX-2) activity in vitro","volume":"47","author":"Futaki","year":"1994","journal-title":"Prostaglandins"},{"key":"10.1016\/j.cca.2009.12.026_bib20","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1053\/gast.2000.16510","article-title":"NSAID-induced gastric damage in rats: requirement for inhibition of both cyclooxygenase 1 and 2","volume":"119","author":"Wallace","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cca.2009.12.026_bib21","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0928-4257(01)00005-5","article-title":"Inhibition of both COX-1 and COX-2 is required for development of gastric damage in response to nonsteroidal anti-inflammatory drugs","volume":"95","author":"Tanaka","year":"2001","journal-title":"J Physiol Paris"},{"key":"10.1016\/j.cca.2009.12.026_bib22","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1124\/jpet.300.3.754","article-title":"Up-regulation of COX-2 by inhibition of COX-1: a key to NSAID-induced intestinal damage","volume":"300","author":"Tanaka","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.cca.2009.12.026_bib23","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1124\/jpet.102.041715","article-title":"Role of COX-1 and COX-2 inhibition in NSAID-induced intestinal damage in rats: relation to various pathogenic events","volume":"303","author":"Tanaka","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.cca.2009.12.026_bib24","first-page":"A-565","article-title":"Importance of bile acids in COX-2 and iNOS expressions as well as lesion formation in rat small intestines following administration of indomethacin: relation to farnesoid X receptors","volume":"132","author":"Takahira","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cca.2009.12.026_bib25","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0928-4257(01)00009-2","article-title":"Protection by aspirin of indomethacin-induced small intestinal damage in rats: mediation by salicylic acid","volume":"95","author":"Takeuchi","year":"2001","journal-title":"J Physiol (Paris)"},{"key":"10.1016\/j.cca.2009.12.026_bib26","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1007\/s10620-006-8045-4","article-title":"Factors involved in up-regulation of inducible nitric oxide synthase in rat small intestine following administration of nonsteroidal antiinflammatory drugs","volume":"51","author":"Takeuchi","year":"2006","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cca.2009.12.026_bib27","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/j.1440-1746.1994.tb01284.x","article-title":"Gastric cytoprotection by amoxicillin in the rat","volume":"9","author":"Lam","year":"1994","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.cca.2009.12.026_bib28","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1124\/jpet.104.065961","article-title":"Induction of small intestinal damage in rats following combined treatment with cyclooxygenase-2 and nitric oxide synthase inhibitors","volume":"310","author":"Ohno","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.cca.2009.12.026_bib29","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1159\/000064419","article-title":"Pathogenic importance of intestinal hypermotility in NSAID-induced small intestinal damage in rats","volume":"66","author":"Takeuchi","year":"2002","journal-title":"Digestion"},{"key":"10.1016\/j.cca.2009.12.026_bib30","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/gut.2007.125963","article-title":"Nonsteroidal anti-inflammatory drug-induced small intestinal damage is toll-like receptor 4 dependent","volume":"57","author":"Watanabe","year":"2008","journal-title":"Gut"},{"key":"10.1016\/j.cca.2009.12.026_bib31","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1254\/jjp.88.45","article-title":"Protective effect of thiaton, the anti-spasmodic drug, against indomethacin-induced intestinal ulceration in rats","volume":"88","author":"Kunikata","year":"2002","journal-title":"Jpn J Pharmacol"},{"key":"10.1016\/j.cca.2009.12.026_bib32","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1111\/j.1476-5381.1993.tb13940.x","article-title":"The induction of nitric oxide synthase and intestinal vascular permeability by endotoxin in the rat","volume":"110","author":"Boughton-Smith","year":"1993","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.cca.2009.12.026_bib33","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1440-1746.2004.03520.x","article-title":"Mechanism underlying up-regulation of COX-2 in rat small intestine under inhibition of COX-1: relation to intestinal hypermotility","volume":"20","author":"Tanaka","year":"2005","journal-title":"J Gastroent Hepathol"},{"key":"10.1016\/j.cca.2009.12.026_bib34","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1111\/j.1476-5381.1995.tb15066.x","article-title":"Inducible nitric oxide synthase and microvascular injury in the rat jejunum provoked by indomethacin","volume":"116","author":"Whittle","year":"1995","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.cca.2009.12.026_bib35","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0928-4257(01)00007-9","article-title":"Protection by constitutively formed nitric oxide of intestinal damage induced by indomethacin in rats","volume":"95","author":"Tanaka","year":"2001","journal-title":"J Physiol Paris"},{"key":"10.1016\/j.cca.2009.12.026_bib36","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1046\/j.1365-2036.2001.00916.x","article-title":"Lack of small intestinal toxicity of nitric oxide-releasing indomethacin, NCX-530, in rats","volume":"15","author":"Mizoguchi","year":"2001","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cca.2009.12.026_bib37","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1365-2036.1993.tb00066.x","article-title":"Early histological features of small intestinal injury induced by indomethacin","volume":"7","author":"Anthony","year":"1993","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cca.2009.12.026_bib38","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1136\/gut.41.6.763","article-title":"Vascular anatomy defines sites of indomethacin induced jejunal ulceration along the mesenteric margin","volume":"41","author":"Anthony","year":"1997","journal-title":"Gut"},{"key":"10.1016\/j.cca.2009.12.026_bib39","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1073\/pnas.87.4.1620","article-title":"Apparent hydroxyl radicals production by peroxyl radical production by peroxynitrite: implication for endothelial injury from nitric oxide and superoxide","volume":"87","author":"Beckman","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cca.2009.12.026_bib40","first-page":"G688","article-title":"Cyclooxygenase-2 downregulates inducible nitric oxide synthase in rat intestinal epithelial cells","volume":"281","author":"Kobayashi","year":"2001","journal-title":"Am J Physiol"},{"key":"10.1016\/j.cca.2009.12.026_bib41","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2174\/1381612013398464","article-title":"Gastrointestinal sparing anti-inflammatory drugs: effects on ulcerogenic and healing responses","volume":"7","author":"Takeuchi","year":"2001","journal-title":"Current Pharmaceutical Design"},{"key":"10.1016\/j.cca.2009.12.026_bib42","first-page":"A-97","article-title":"Antiulcer effect of aspirin","volume":"72","author":"Robert","year":"1973","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cca.2009.12.026_bib43","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0090-6980(81)90130-1","article-title":"Gastric cytoprotection by sodium salicylate","volume":"21","author":"Robert","year":"1981","journal-title":"Prostaglandins"},{"key":"10.1016\/j.cca.2009.12.026_bib44","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1023\/A:1015867119014","article-title":"Prevention by parenteral aspirin of indomethacin-induced gastric lesions in rats: mediation by salicylic acid","volume":"47","author":"Komoike","year":"2002","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cca.2009.12.026_bib45","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1007\/s00535-009-0040-z","article-title":"Characteristics of small bowel injury in symptomatic chronic low-dose aspirin users: the experience of two medical centers in capsule endoscopy","volume":"44","author":"Endo","year":"2009","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.cca.2009.12.026_bib46","doi-asserted-by":"crossref","unstructured":"Shiotani A, Haruma K, Nishi R, Fujita M, Kamada T, Honda K, Kusunoki H, Hata J, Graham DY. Randomized, double-blind, pilot study of geranylgeranylacetone versus placebo in patients taking low-dose enteric-coated aspirin. Low-dose aspirin-induced small bowel damage. Scand J Gastroenterol, in press. [doi:10.3109\/00365520903453182].","DOI":"10.3109\/00365520903453182"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898110000112?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898110000112?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T14:42:12Z","timestamp":1757860932000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898110000112"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":46,"journal-issue":{"issue":"7-8","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["S0009898110000112"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2009.12.026","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2010,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Roles of COX inhibition in pathogenesis of NSAID-induced small intestinal damage","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2009.12.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}